Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Fatigue: Biomedicine, Health & Behavior
19 November 2019
https://www.tandfonline.com/doi/abs/10.1080/21641846.2019.1692770?journalCode=rftg20

Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists

Br J Pharmacol
July 2007
https://pubmed.ncbi.nlm.nih.gov/17502848/

Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities (Abstract)

Am J Ment Retard
July 2001
https://pubmed.ncbi.nlm.nih.gov/11414874/

Erratum: in Table 1 a column heading was inadvertently omitted. See Am J Ment Retard 2001 Sep;106(5):469

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study

Pain Med
May-June 2009
https://pubmed.ncbi.nlm.nih.gov/19453963/

Objective: Fibromyalgia is a chronic pain disorder that is characterized by diffuse musculoskeletal pain and sensitivity to mechanical stimulation. In this pilot clinical trial, we tested the effectiveness of low-dose naltrexone in treating the symptoms of fibromyalgia.

Oxytrex: an oxycodone and ultra-low-dose naltrexone formulation

Expert Opin Investig Drugs
August 2007
https://www.ncbi.nlm.nih.gov/pubmed/17685875

Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers

Am J Ment Retard
September 1997
https://www.ncbi.nlm.nih.gov/pubmed/?term=9327093

Effect of transcutaneous electrical stimulation on nociception and edema induced by peripheral serotonin

Int J Neurosc
July 2013
https://www.ncbi.nlm.nih.gov/pubmed/23336713

Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study

J Opioid Manag
May-Jun 2007
https://pubmed.ncbi.nlm.nih.gov/18027539/

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis

J Mult Scler
September 2008
https://www.ncbi.nlm.nih.gov/pubmed/18728058

Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling

J Pain
August 2008
https://www.ncbi.nlm.nih.gov/pubmed/18468954